NanoBio Corporation reported top-level findings today from its phase 2b study of NB-001, a topical lotion to treat herpes labialis (cold sores). The randomized, double-blind, vehicle- controlled study met its primary and secondary endpoints by demonstrating clear efficacy and safety in 482 patients.
Tegal Corporation, a leading designer and manufacturer of plasma etch and deposition systems used in the production of integrated circuits, MEMS, and nanotechnology devices, today announced that it has signed an agreement with WESI Technology (China) for sales distribution as well as service and technical support of Tegal's plasma etch and PVD products in China and Taiwan.
A grant, funded by the New Hampshire Innovation Research Center, will enable Presstek and the University of New Hampshire to conduct leading-edge nanotechnology research with the goal of advancing printing technology.
IBM scientists today took another significant advance towards sending information inside a computer chip by using light pulses instead of electrons by building the world?s tiniest nanophotonic switch with a footprint about 100X smaller than the cross section of a human hair.
mPhase Technologies Inc. today announced the launch of its new website designed to showcase its revolutionary Smart NanoBattery. The website articulates the nanotechnology based breakthrough, history, awards and articles that highlight the benefits of mPhase/AlwaysReady Smart NanoBattery.
Sunovia Energy Technologies, Inc. and EPIR Technologies, Inc. announced the completion of Phase I of the expansion of the world class Electro-Optic manufacturing facilities at EPIR in Bolingbrook, Ill., just west of Chicago.
Arrowhead Research Corporation's Chief Executive Officer, Christopher Anzalone, presented a slide show entitled 'Creating Value by Building Nanobusiness from Nanoscience' following Arrowhead's Annual Meeting of Stockholders.
API Nanotronics, Corp., a leading supplier of electronic components and nanotechnology research and development to the defense and communications sectors, today announced record orders of more than $9.0 million for the third quarter ended February 29, 2008.
Arrowhead Research Corporation announced today that its majority owned subsidiary, Calando Pharmaceuticals, a leading siRNA therapeutics company, submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration to initiate a Phase I clinical trial using their lead anti-cancer compound, CALAA-01.
Researchers at TopChim, a developer of materials and technology solutions for the paper industry, have integrated the Zetasizer Nano particle characterization system from Malvern Instruments into the company?s nanoscience development program.